BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14559863)

  • 1. New charity chief discusses his fast-paced agenda.
    Illman J
    J Natl Cancer Inst; 2003 Oct; 95(20):1502-3. PubMed ID: 14559863
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 3. McVie calls for reduction in cancer charity numbers.
    Dickson D
    Nat Med; 1998 Jun; 4(6):650. PubMed ID: 9623959
    [No Abstract]   [Full Text] [Related]  

  • 4. Government and charity funding of cancer research: public preferences and choices.
    Shah KK; Sussex J; Hernandez-Villafuerte K
    Health Res Policy Syst; 2015 Sep; 13():38. PubMed ID: 26335693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charity calls for ban on tobacco industry funding of research.
    Gould M
    BMJ; 2002 Aug; 325(7358):238. PubMed ID: 12153917
    [No Abstract]   [Full Text] [Related]  

  • 6. UK charities pick up the tab left by government shortfall.
    Hadlington S
    Nature; 1987 Jul 9-15; 328(6126):99. PubMed ID: 3600797
    [No Abstract]   [Full Text] [Related]  

  • 7. A survey of public funding of cancer research in the European union.
    Eckhouse S; Sullivan R
    PLoS Med; 2006 Jul; 3(7):e267. PubMed ID: 16842021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer research funding in Europe low compared with U.S., survey finds.
    Illman J
    J Natl Cancer Inst; 2005 May; 97(10):713-4. PubMed ID: 15900040
    [No Abstract]   [Full Text] [Related]  

  • 9. Reflection and anticipation: views from the MRC and the charities. Interview by Richard Smith.
    Rees D; Kemp N
    Br Med J (Clin Res Ed); 1988 Apr; 296(6628):1054-7. PubMed ID: 3130136
    [No Abstract]   [Full Text] [Related]  

  • 10. Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding.
    Begum M; Lewison G; Lawler M; Sullivan R
    Eur J Cancer; 2018 Sep; 100():75-84. PubMed ID: 30014883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed US Government budget cuts would 'devastate' cancer research.
    Furlow B
    Lancet Oncol; 2017 May; 18(5):577. PubMed ID: 28343979
    [No Abstract]   [Full Text] [Related]  

  • 12. More or less. What effect might cutting the number of cancer charities have on nursing care?
    George M
    Nurs Stand; 1998 Jul 22-28; 12(44):27. PubMed ID: 9791464
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncology issues in health care reform.
    Kennedy BJ
    Cancer Invest; 1994; 12(2):249-56. PubMed ID: 8131102
    [No Abstract]   [Full Text] [Related]  

  • 14. Government should ringfence funding for national cancer strategy, urges charity.
    Iacobucci G
    BMJ; 2017 Feb; 356():j733. PubMed ID: 28183727
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical charities and prevention.
    Bodmer W
    Br Med J; 1980 Jan; 280(6208):178-9. PubMed ID: 7357305
    [No Abstract]   [Full Text] [Related]  

  • 16. Two British cancer charities may join forces.
    Illman J
    J Natl Cancer Inst; 2001 Sep; 93(17):1289-90. PubMed ID: 11535699
    [No Abstract]   [Full Text] [Related]  

  • 17. The funding of medical research: going up or coming down?
    Smith R
    Br Med J (Clin Res Ed); 1988 Jan; 296(6617):267-70. PubMed ID: 3124907
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer charities diversify to weather economic storm.
    Burki T
    Lancet Oncol; 2010 Apr; 11(4):319. PubMed ID: 20369405
    [No Abstract]   [Full Text] [Related]  

  • 19. Mapping the biomedical research landscape.
    Birmingham K
    Nat Med; 1998 Aug; 4(8):877. PubMed ID: 9701228
    [No Abstract]   [Full Text] [Related]  

  • 20. Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer Research.
    Vose JM
    Oncology (Williston Park); 2015 Sep; 29(9):613, 615. PubMed ID: 26391037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.